Yoshikazu Nakaoka

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 18

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Modern rheumatology

Journal of the American Heart Association

American journal of physiology. Heart and circulatory physiology

National Cerebral and Cardiovascular Center

Osaka University Graduate School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Cerebral and Cardiovascular Center Jan 01 2016

Japan

Director :: Department of Vascular Physiology

Osaka University Apr 01 2007 - Dec 31 2015

Japan

Associate Professor :: Depaertment of Cardiovascular Medicine, Graduate School of Medicine

Education History

Osaka University Graduate School of Medicine Apr 01 2000 - Mar 31 2004

Japan

PHD :: Department of Cardiovascular Medicine

Publications

Tomohiko Ishibashi, Tadakatsu Inagaki, Makoto Okazawa, Akiko Yamagishi, Keiko Ohta-Ogo, Ryotaro Asano, Takeshi Masaki, Yui Kotani, Xin Ding, Tomomi Chikaishi-Kirino, Noriko Maedera, Manabu Shirai, Kinta Hatakeyama, Yoshiaki Kubota, Tadamitsu Kishimoto, Yoshikazu Nakaoka
IL-6/gp130 signaling in CD4 + T cells drives the pathogenesis of pulmonary hypertension. Proceedings of the National Academy of Sciences of the United States of America 121 (16) (2024)
Tomohiko Ishibashi, Tadakatsu Inagaki, Makoto Okazawa, Akiko Yamagishi, Keiko Ohta-Ogo, Ryotaro Asano, Takeshi Masaki, Yui Kotani, Xin Ding, Tomomi Chikaishi-Kirino, Noriko Maedera, Manabu Shirai, Kinta Hatakeyama, Yoshiaki Kubota, Tadamitsu Kishimoto, Yoshikazu Nakaoka
IL-6/gp130 signaling in CD4 + T cells drives the pathogenesis of pulmonary hypertension. Proceedings of the National Academy of Sciences of the United States of America 121 (16) (2024)
Tomohiko Ishibashi, Tadakatsu Inagaki, Makoto Okazawa, Akiko Yamagishi, Keiko Ohta-Ogo, Ryotaro Asano, Takeshi Masaki, Yui Kotani, Xin Ding, Tomomi Chikaishi-Kirino, Noriko Maedera, Manabu Shirai, Kinta Hatakeyama, Yoshiaki Kubota, Tadamitsu Kishimoto, Yoshikazu Nakaoka
IL-6/gp130 signaling in CD4 + T cells drives the pathogenesis of pulmonary hypertension. Proceedings of the National Academy of Sciences of the United States of America 121 (16) (2024)
Tomohiko Ishibashi, Tadakatsu Inagaki, Makoto Okazawa, Akiko Yamagishi, Keiko Ohta-Ogo, Ryotaro Asano, Takeshi Masaki, Yui Kotani, Xin Ding, Tomomi Chikaishi-Kirino, Noriko Maedera, Manabu Shirai, Kinta Hatakeyama, Yoshiaki Kubota, Tadamitsu Kishimoto, Yoshikazu Nakaoka
IL-6/gp130 signaling in CD4 + T cells drives the pathogenesis of pulmonary hypertension. Proceedings of the National Academy of Sciences of the United States of America 121 (16) (2024)
Takatoyo Kiko, Ryotaro Asano, Tomohiko Ishibashi, Hiroyuki Endo, Naruhiro Nishi, Hiroya Hayashi, Jin Ueda, Tatsuo Aoki, Akihiro Tsuji, Yoshikazu Nakaoka, Takeshi Ogo
Prevalence and Clinical Characteristics of Heterozygous RNF213 p.Arg4810Lys Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary Hypertension. Journal of the American Heart Association (2024)
Takatoyo Kiko, Ryotaro Asano, Tomohiko Ishibashi, Hiroyuki Endo, Naruhiro Nishi, Hiroya Hayashi, Jin Ueda, Tatsuo Aoki, Akihiro Tsuji, Yoshikazu Nakaoka, Takeshi Ogo
Prevalence and Clinical Characteristics of Heterozygous RNF213 p.Arg4810Lys Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary Hypertension. Journal of the American Heart Association 13 (15) (2024)
Yoshiyuki Abe, Takao Fujii, Yoshia Miyawaki, Takahiko Sugihara, Haruhito Adam Uchida, Yasuhiro Maejima, Yoshiko Watanabe, Takuya Hashimoto, Takako Miyamae, Yoshikazu Nakaoka, Masayoshi Harigai, Naoto Tamura
The real-world clinical decisions of physicians in the management of Takayasu arteritis and giant cell arteritis in Japan: A cross-sectional web-questionnaire survey. Modern rheumatology (2024)
Tomohiko Ishibashi, Tadakatsu Inagaki, Makoto Okazawa, Akiko Yamagishi, Keiko Ohta-Ogo, Ryotaro Asano, Takeshi Masaki, Yui Kotani, Xin Ding, Tomomi Chikaishi-Kirino, Noriko Maedera, Manabu Shirai, Kinta Hatakeyama, Yoshiaki Kubota, Tadamitsu Kishimoto, Yoshikazu Nakaoka
IL-6/gp130 signaling in CD4 + T cells drives the pathogenesis of pulmonary hypertension. Proceedings of the National Academy of Sciences of the United States of America 121 (16) (2024)
Hideo Ohuchi, Ryotaro Asano, Aki Mori, Tomohiko Ishibashi, Daisuke Motooka, Michikazu Nakai, Yoshikazu Nakaoka
Gut Dysbiosis in Patients With Fontan Circulation. Journal of the American Heart Association (2024)
Tomohiko Ishibashi, Tadakatsu Inagaki, Makoto Okazawa, Akiko Yamagishi, Keiko Ohta-Ogo, Ryotaro Asano, Takeshi Masaki, Yui Kotani, Xin Ding, Tomomi Chikaishi-Kirino, Noriko Maedera, Manabu Shirai, Kinta Hatakeyama, Yoshiaki Kubota, Tadamitsu Kishimoto, Yoshikazu Nakaoka
IL-6/gp130 signaling in CD4 + T cells drives the pathogenesis of pulmonary hypertension. Proceedings of the National Academy of Sciences of the United States of America 121 (16) (2024)
Masayoshi Harigai, Takako Miyamae, Hideyuki Hashimoto, Kosei Umetsu, Katsuhisa Yamashita, Yoshikazu Nakaoka
A multicentre, large-scale, observational study of tocilizumab in patients with giant cell arteritis in Japan. Modern rheumatology (2023)
Naoko Konda, Ryoko Sakai, Keigo Saeki, Yuri Matsubara, Yosikazu Nakamura, Takako Miyamae, Yoshikazu Nakaoka, Masayoshi Harigai
Nationwide clinical and epidemiological study of large-vessel vasculitis in Japan in 2017. Modern rheumatology (2023)
Yusuke Manabe, Tomohiko Ishibashi, Ryotaro Asano, Shuichi Tonomura, Yuichi Maeda, Daisuke Motooka, Jin Ueda, Masahiro Yanagawa, Yuko Edamoto-Taira, Tomomi Chikaishi-Kirino, Takeshi Masaki, Tadakatsu Inagaki, Shota Nakamura, Yoshinori Katada, Makoto Okazawa, Masashi Narazaki, Takeshi Ogo, Atsushi Kumanogoh, Yoshikazu Nakaoka
Gut dysbiosis is associated with aortic aneurysm formation and progression in Takayasu arteritis. Arthritis research & therapy 25 (1) (2023)
Ai Yaku, Tadakatsu Inagaki, Ryotaro Asano, Makoto Okazawa, Hiroyoshi Mori, Ayuko Sato, Fabian Hia, Takeshi Masaki, Yusuke Manabe, Tomohiko Ishibashi, Alexis Vandenbon, Yoshinari Nakatsuka, Kotaro Akaki, Masanori Yoshinaga, Takuya Uehata, Takashi Mino, Satoshi Morita, Hatsue Ishibashi-Ueda, Akio Morinobu, Tohru Tsujimura, Takeshi Ogo, Yoshikazu Nakaoka, Osamu Takeuchi
Regnase-1 Prevents Pulmonary Arterial Hypertension Through mRNA Degradation of Interleukin-6 and Platelet-Derived Growth Factor in Alveolar Macrophages. Circulation 146 (13) (2022)
Masayoshi Harigai, Takako Miyamae, Hideyuki Hashimoto, Amika Yoshida, Katsuhisa Yamashita, Yoshikazu Nakaoka
A Multicentre, Large-Scale, Observational Study of Tocilizumab in Patients with Takayasu Arteritis in Japan: The ACT-Bridge Study. Modern rheumatology (2022)
Takeshi Masaki, Makoto Okazawa, Ryotaro Asano, Tadakatsu Inagaki, Tomohiko Ishibashi, Akiko Yamagishi, Saori Umeki-Mizushima, Manami Nishimura, Yusuke Manabe, Hatsue Ishibashi-Ueda, Manabu Shirai, Hirotsugu Tsuchimochi, James T Pearson, Atsushi Kumanogoh, Yasushi Sakata, Takeshi Ogo, Tadamitsu Kishimoto, Yoshikazu Nakaoka
Aryl hydrocarbon receptor is essential for the pathogenesis of pulmonary arterial hypertension. Proceedings of the National Academy of Sciences of the United States of America 118 (11) (2021)
Tadakatsu Inagaki, James T Pearson, Hirotsugu Tsuchimochi, Daryl O Schwenke, Shigeyoshi Saito, Takahiro Higuchi, Takeshi Masaki, Keiji Umetani, Mikiyasu Shirai, Yoshikazu Nakaoka
Evaluation of right coronary vascular dysfunction in severe pulmonary hypertensive rats using synchrotron radiation microangiography. American journal of physiology. Heart and circulatory physiology 320 (3) (2021)
Takafumi Minato, Satoru Nirasawa, Teruki Sato, Tomokazu Yamaguchi, Midori Hoshizaki, Tadakatsu Inagaki, Kazuhiko Nakahara, Tadashi Yoshihashi, Ryo Ozawa, Saki Yokota, Miyuki Natsui, Souichi Koyota, Taku Yoshiya, Kumiko Yoshizawa-Kumagaye, Satoru Motoyama, Takeshi Gotoh, Yoshikazu Nakaoka, Josef M Penninger, Hiroyuki Watanabe, Yumiko Imai, Saori Takahashi, Keiji Kuba
B38-CAP is a bacteria-derived ACE2-like enzyme that suppresses hypertension and cardiac dysfunction. Nature communications 11 (1) (2020)

Yoshikazu Nakaoka.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yoshikazu Nakaoka